The history and evolution of immigration medical screening for tuberculosis

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 2, 2013, Pages 137-146

  Dara, Masoud ^a   Gushulak, Brian D ^b   Posey, Drew L ^c   Zellweger, Jean Pierre ^d   Migliori, Giovanni B ^e  

^a WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^b Migration Health Consultants   (Canada)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Swiss Lung Association   (Switzerland)

^e IRCCS   (Italy)

Author keywords

chest radiography; control; elimination; immigrants; screening; tuberculosis

Indexed keywords

ARTICLE; DIAGNOSTIC TEST; DISEASE TRANSMISSION; HEALTH CARE POLICY; HIGH RISK POPULATION; HISTORY OF MEDICINE; HUMAN; IMMIGRANT; IMMIGRATION MEDICAL SCREENING; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MEDICAL PRACTICE; MOLECULAR DIAGNOSIS; NONHUMAN; PATIENT IDENTIFICATION; PHYSICAL EXAMINATION; POSTPRIMARY TUBERCULOSIS; PREVALENCE; SCREENING; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

CANADA; EMIGRANTS AND IMMIGRANTS; EMIGRATION AND IMMIGRATION; HISTORY, 20TH CENTURY; HUMANS; MANDATORY TESTING; TUBERCULOSIS; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 84873920317     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.168     Document Type: Article

References (71)

1. Parascandola J. Doctors at the gate. PHS at Ellis Island. Public Health Rep. 113(1), 83-86 (1998).
2. Clark DA. Medical aspect of immigration. Public Health J. 18, 371-375 (1926).
3. Anonymous. The Immigration Medical Services for Canada. Can. Med. Assoc. J. 24(3), 435 (1931)
4. Dara M, de Colombani P, Petrova-Benedict R et al; Members of the Wolfheze Transborder Migration Task Force. The minimum package for cross-border TB control and care in the WHO European region: a Wolfheze Consensus Statement. Eur. Respir. J. 40(5),1081-1090 (2012).
5. Alvarez GG, Gushulak B, Abu Rumman K et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect. Dis. 11, 3 (2011).
6. Osler W. On the study of tuberculosis. Phil. Med. J. 6, 1029-1030 (1900).
7. Anonymous. Modern views on tuberculosis. Can. Med. Assoc. J. 10, 1137-1140 (1920).
8. Anonymous. A discussion on the use of x-rays in the diagnosis of pulmonary tuberculosis. Proc. R. Soc. Med. 6, 93-99 (1913).
9. Thompson BC. Mass radiography: a new weapon against tuberculosis. Postgrad. Med. J. 20(222), 131-135 (1944).
10. US Public Health Service. Manual for Medical Examination of Aliens. US Public Health Service, Washington, DC, USA (1956).
11. Marais BJ, Gie RP, Schaaf HS et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int. J. Tuberc. Lung Dis. 8(3), 278-285 (2004).
12. Riviere C. A Lecture on the principles of treatment of pulmonary tuberculosis. Br. Med. J. 1(3409), 771-775 (1926).
13. Tadolini M, Migliori GB. The WHO strategy for tuberculosis control and elimination. Eur. Respir. Mon. 58, 1-12 (2012).
14. D'Ambrosio L, Centis R, Migliori GB. Multidrug-resistant tuberculosis. N. Engl. J. Med. 367(22), 2154; author reply 2155-2154; author reply 2156 (2012).
15. Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N. Engl. J. Med. 364(15), 1441-1448 (2011).
16. Ploubidis GB, Palmer MJ, Blackmore C et al. Social determinants of tuberculosis in Europe: a prospective ecological study. Eur. Respir. J. 40(4), 925-930 (2012).
17. Rabe KF, Ward B. Uncovering and tackling Europe's hidden respiratory illness. Lancet 380(9842), 623-624 (2012).
18. Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 14(1), 15-23 (2010).
19. Erkens C, Slump E, Kamphorst M et al. Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants. Eur. Respir. J. 32(1), 153-161 (2008).
20. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 278(4), 304-307 (1997).
21. Bloch AB, Rieder HL, Kelly GD, Cauthen GM, Hayden CH, Snider DE Jr. The epidemiology of tuberculosis in the United States. Implications for diagnosis and treatment. Clin. Chest Med. 10(3), 297-313 (1989).
22. Rieder HL. Epidemiology of tuberculosis in Europe. Eur. Respir. J. Suppl. 20, S620-S632 (1995).
23. Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB. Tuberculosis control in Europe and international migration. Eur. Respir. J. 7(8), 1545-1553 (1994).
24. Verver S, Bwire R, Borgdorff MW. Screening for pulmonary tuberculosis among immigrants: estimated effect on severity of disease and duration of infectiousness. Int. J. Tuberc. Lung Dis. 5(5), 419-425 (2001).
25. Raviglione MC, Uplekar MW. WHO's new Stop TB Strategy. Lancet 367(9514), 952-955 (2006).
26. Brummer DL. Preventive therapy of tuberculosis. Annu. Rev. Med. 25, 115-122 (1974).
27. O'Brien RJ. Preventive therapy for tuberculosis. In:Tuberculosis: Back to the Future. Porter JDH, McAdam KPWJ (Eds). Wiley, Chichester, USA, 151-166 (1994).
28. Arshad S, Bavan L, Gajari K, Paget SN, Baussano I. Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur. Respir. J. 35(6), 1336-1345 (2010).
29. Schneeberger Geisler S, Helbling P, Zellweger JP, Altpeter ES. Screening for tuberculosis in asylum seekers: comparison of chest radiography with an interviewbased system. Int. J. Tuberc. Lung Dis. 14(11), 1388-1394 (2010).
30. Klinkenberg E, Manissero D, Semenza JC, Verver S. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur. Respir. J. 34(5), 1180-1189 (2009).
31. Mor Z, Lerman Y, Leventhal A. Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel. Eur. Respir. J. 32(2), 413-418 (2008).
32. Mor Z, Lerman Y, Leventhal A. Pre-immigration screening for pulmonary tuberculosis. Eur. Respir. J. 33(3), 701-702 (2009).
33. Bhuniya S. Pre-immigration screening for pulmonary tuberculosis: the unanswered questions. Eur. Respir. J. 33(1), 221-222 (2009).
34. Dirks GE. Canada's Refugee Policy - Indifference or Opportunism. McGill- Queen's University Press, QC, Canada (1977).
35. Flynn M, Brown L, Tesfai A, Lauer T. Post-migration screening for active tuberculosis in Victoria, Australia. Int. J. Tuberc. Lung Dis. 16(1), 50-54 (2012).
36. Christenson B. [Panorama of infections among refugees - the risk of epidemics from the East]. Nord. Med. 110(2), 40-1, 47 (1995).
37. Barniol J, Niemann S, Louis VR et al. Transmission dynamics of pulmonary tuberculosis between autochthonous and immigrant sub-populations. BMC Infect. Dis. 9, 197 (2009).
38. Pareek M, Baussano I, Abubakar I, Dye C, Lalvani A. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg. Infect. Dis. 18(9), 1422-1429 (2012).
39. Pareek M, Watson JP, Ormerod LP et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect. Dis. 11(6), 435-444 (2011).
40. Sarivalasis A, Zellweger J, Faouzi M, Daher O, Deslarzes C, Bodenmann P. Factors associated with latent tuberculosis among asylum seekers in Switzerland: a crosssectional study in Vaud County. BMC Infect. Dis. 12(1), 285 (2012).
41. Ricks PM, Cain KP, Oeltmann JE, Kammerer JS, Moonan PK. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009. PLoS ONE 6(11), e27405 (2011).
42. Mulder C, van Deutekom H, Huisman EM et al. Role of quantiferon-tb gold in-tube in screening new immigrants for tuberculosis infection. Eur. Respir. J. 40(6), 1443-1449 (2012).
43. Meima A, de Vlaas SJ. Pulmonary Tuberculosis Incidence in migrants, ECDC project 572, April 2008. Erasmus University Department of Public Health, Rotterdam, The Netherlands. 44 Lalvani A, Pareek M. Interferon ? release assays: principles and practice. Enferm. Infecc. Microbiol. Clin. 28(4), 245-252 (2010).
44. Abubakar I, Story A, Lipman M et al. Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population. Eur. Respir. J. 35(3), 689-692 (2010).
45. WHO. Toman's Tuberculosis: Case Detection, Treatment, and Monitoring (2nd Edition). WHO, Geneva, Switzerland, WHO/HTM/TB/2004.334 (2004).
46. Zellweger JP, Heinzer R, Touray M, Vidondo B, Altpeter E. Intra-observer and overall agreement in the radiological assessment of tuberculosis. Int. J. Tuberc. Lung Dis. 10(10), 1123-1126 (2006).
47. Maloney SA, Fielding KL, Laserson KF et al. Assessing the performance of overseas tuberculosis screening programs: a study among US-bound immigrants in Vietnam. Arch. Intern. Med. 166(2), 234-240 (2006).
48. Santin Cerezales M, Navas Elorza E. Tuberculosis in special populations. Enferm. Infecc. Microbiol. Clin. 29( Suppl. 1), 20-25 (2011).
49. Breuss E, Helbling P, Altpeter E, Zellweger JP. Screening and treatment for latent tuberculosis infection among asylum seekers entering Switzerland. Swiss Med. Wkly 132(15-16), 197-200 (2002).
50. Metcalfe JZ, Everett CK, Steingart KR et al. Interferon-? release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J. Infect. Dis. 204(Suppl. 4), S1120-S1129 (2011).
51. Nienhaus A, Schablon A, Costa JT, Diel R. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv. Res. 11, 247 (2011).
52. Mulder C, van Deutekom H, Huisman EM et al. Role of the QuantiFERON-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection. Eur. Respir. J. 40(6), 1443-1449 (2012).
53. Kik SV, Franken WP, Mensen M et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur. Respir. J. 35(6), 1346-1353 (2010).
54. Diel R, Goletti D, Ferrara G et al. Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37(1), 88-99 (2011).
55. Evans CA. GeneXpert - a game-changer for tuberculosis control? PLoS Med. 8(7), e1001064 (2011).
56. Weyer K, Mirzayev F, Migliori G et al. Rapid molecular TB diagnosis: evidence, policy-making and global implementation of XpertMTB/RIF. Eur. Respir. J. doi:10.1183/09031936.00157212 (2012) (Epub ahead of print).
57. Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K. Xpert MTB/RIF for diagnosis of TB and drug-resistant TB: a cost and affordability analysis. Eur. Respir. J. doi: 10.1183/09031936.00147912(2012) (Epub ahead of print).
58. George SA, Ko CA, Kirchner HL, Starke JR, Dragga TA, Mandalakas AM. The role of chest radiographs and tuberculin skin tests in tuberculosis screening of internationally adopted children. Pediatr. Infect. Dis. J. 30(5), 387-391 (2011).
59. Cain KP, Mac Kenzie WR, Castro KG, LoBue PA. No man is an island: reducing diagnostic delays in undocumented foreignborn persons is needed to decrease the risk of tuberculosis transmission. Clin. Infect. Dis. 47(10), 1284-1286 (2008).
60. Broekmans JF, Migliori GB, Rieder HL et al.; World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur. Respir. J. 19(4), 765-775 (2002).
61. Veen J, Migliori GB, Raviglione M et al. Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops. Eur. Respir. J. 37(4), 950-959 (2011).
62. Borgdorff MW, van den Hof S, Kremer K et al. Progress towards tuberculosis elimination: secular trend, immigration and transmission. Eur. Respir. J. 36(2), 339-347 (2010).
63. Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur. Respir. J. 25(6), 1107-1116 (2005).
64. Erkens CG, Kamphorst M, Abubakar I et al. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur. Respir. J. 36(4), 925-949 (2010).
65. Heldal E, Kuyvenhoven JV, Wares F et al. Diagnosis and treatment of tuberculosis in undocumented migrants in low- or intermediate-incidence countries. Int. J. Tuberc. Lung Dis. 12(8), 878-888 (2008).
66. King K, Douglas PJ, Beath K. Is premigration health screening for tuberculosis worthwhile? Med. J. Aust. 195(9), 534-537 (2011).
67. Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC) (2nd Edition). Tuberculosis Coalition for Technical Assistance, The Hague, The Netherlands (2009).
68. Migliori GB, Zellweger JP, Abubakar I et al. European union standards for tuberculosis care. Eur. Respir. J. 39(4), 807-819 (2012).
69. Schwartzman K, Oxlade O, Barr RG et al. Domestic returns from investment in the control of tuberculosis in other countries. N. Engl. J. Med. 353(10), 1008-1020 (2005).
70. An Act to amend the Immigration Act, 1919 (Can.), c. 25. www.canadiana.org/ECO/Item-Record/9-08048(Accessed 14 September 2012)
71. National Institute for Health and Clinical Excellence Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. March 2006. www.nice.org.uk/nicemedia/pdf/ CG033niceguideline.pdf(Accessed 14 September 2012)